The Therapeutic Goods Administrations has has conditionally approved the COVID129 vaccine COMIRNATY for use in children ages 5 and older.
The first shipments are expected to land before Christmas.
Despite Chief Medical Officer Professor Paul Kelly recommending shortening the time between the second and third dose, the Australian Technical Advisory Group on Immunisation has decided to keep the current 6 month interval.